Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie
Abstract
The follow-up of renal cancer is essentially based on thoracoabdominal computed tomography (CT). The duration of this follow-up and the frequency of examinations depend on the patient's level of risk. Early detection of metastases has a limited therapeutic value at the present time, apart from tumours with a good prognosis or for the management of complications. Recent publications on targeted treatments raise new hopes and may lead to a modification of follow-up guidelines.
Source and rights
Published by Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2005. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2005
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
- PubMed
- 16459664
- Added to Prognia
- 23 July 2026
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
